Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

AstraZeneca · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
non
metastatic castration-sensitive prostate cancer, azd5305; saruparib; hrrm; non-hrrm; mcspc; prostate cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 890464
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.